Forte: Positive FB102 Vitiligo Treatment Data And Argenx Acquisition For $2.2 Billion
This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science background to generate long term value from Healthcare. He is the author of the investing group Biotech Analysis Central which contains a library of 600+ Biotech investing articles, a model portfolio…